Hanson Kristopher 4

What Happened

• Kristopher Hanson, General Counsel of MapLight Therapeutics (MPLT), was granted equity awards on February 5, 2026: 7,730 shares (awarded) and 31,395 derivative shares (RSUs). Both awards were reported at $0.00 (no cash paid). The 31,395 units are restricted stock units (RSUs) that are contingent rights to receive common stock upon vesting.

Key Details

• Transaction date: 2026-02-05; Filing date: 2026-02-09 (Form 4). The filing appears timely.
• Price paid: $0.00 for both the 7,730 shares and the 31,395 RSU units (award/grant).
• Shares owned after transaction: not specified in the filing.
• Footnotes of note:
  • F1: The RSU award vests over time — 1/4th vests on Jan 1, 2027, then 1/16th vests on each subsequent Apr 1, Jul 1, Oct 1 and Jan 1 thereafter, subject to continued service.
  • F2: Each RSU equals a contingent right to one share of voting common stock on vesting.
  • F3: Filing also includes a vesting schedule (1/4 on Feb 5, 2027, then 1/48 monthly) typically used for option grants; the filing lists this schedule but no option exercise/sale was reported in these transactions.
• Transaction code: A = Award/Grant; the second line is listed as a derivative (RSU).

Context

• These were awards (not open-market purchases or sales). RSUs are contingent and convert to actual shares only as they vest, so they do not represent immediate share purchases or sales.
• Awards at $0 are common for employee/exec compensation and do not necessarily signal a buying or selling sentiment; they reflect compensation/retention.